Pioglitazone 15 mg is a medication used to treat type 2 diabetes. It belongs to a class of drugs known as thiazolidinediones, which work by helping the body use insulin more effectively. Pioglitazone 15 mg is also known as Actos and is available in tablet form. It is usually prescribed to be taken once a day, although the exact dosage and duration of treatment will depend on the individual. Taking pioglitazone 15 mg can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes, such as heart disease, stroke, and kidney damage.
Pioglitazone 15 mg works by increasing the body’s sensitivity to insulin. Insulin is a hormone produced by the pancreas that helps the body to use glucose (sugar) from food for energy. In people with type 2 diabetes, the body's cells become resistant to the effects of insulin, meaning that the pancreas has to produce more insulin to keep blood sugar levels stable. By increasing the body’s sensitivity to insulin, pioglitazone 15 mg helps the pancreas to produce less insulin, which can help to improve blood sugar control.
Taking pioglitazone 15 mg can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes. Specifically, pioglitazone 15 mg can help to: • Lower blood sugar levels • Reduce the risk of heart disease • Reduce the risk of stroke • Reduce the risk of kidney damage • Reduce the risk of nerve damage • Reduce the risk of eye damage • Reduce the risk of amputation • Reduce the risk of death from diabetes-related complications
Pioglitazone 15 mg is usually prescribed to people with type 2 diabetes who have not been able to control their blood sugar levels with diet and exercise alone. It is also sometimes prescribed to people with type 2 diabetes who are taking other medications to help control their blood sugar levels.
Like all medications, pioglitazone 15 mg can cause side effects. The most common side effects include: • Weight gain • Swelling in the hands and feet • Headache • Diarrhea • Nausea • Muscle pain • Weakness More serious side effects, such as an increased risk of heart failure, have been reported in some people taking pioglitazone 15 mg. If you experience any of these side effects, you should talk to your doctor as soon as possible.
Pioglitazone 15 mg is a medication used to treat type 2 diabetes. It works by increasing the body’s sensitivity to insulin, which can help to improve blood sugar control and reduce the risk of long-term complications associated with diabetes. Taking pioglitazone 15 mg can also help to reduce the risk of heart disease, stroke, kidney damage, nerve damage, eye damage, amputation, and death from diabetes-related complications. Pioglitazone 15 mg is usually prescribed to people with type 2 diabetes who have not been able to control their blood sugar levels with diet and exercise alone. Although it can be effective, it can also cause side effects, such as weight gain, swelling in the hands and feet, headache, diarrhea, nausea, muscle pain, and weakness. If you experience any of these side effects, you should talk to your doctor as soon as possible.
1.
Even when they are not paying attention, children are still learning.
2.
Survivors of high-risk neuroblastoma face substantial late effects of modern therapies
3.
Kate Middleton Reaches Cancer Treatment Milestone
4.
Pulled Myeloma Drug Improves Survival in Trial
5.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
1.
Breast Cancer Secrets: AI-Powered Precision Medicine
2.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
3.
Surprising Symptoms of Prostate Cancer: What You Need to Know
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation